David P Kodack

David P Kodack

UNVERIFIED PROFILE

Are you David P Kodack?   Register this Author

Register author
David P Kodack

David P Kodack

Publications by authors named "David P Kodack"

Are you David P Kodack?   Register this Author

15Publications

580Reads

11Profile Views

Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer.

NPJ Breast Cancer 2019 15;5. Epub 2019 Jan 15.

Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-018-0100-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333771PMC
January 2019

Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?

Breast Cancer Res Treat 2017 09 22;165(2):467-468. Epub 2017 Jun 22.

Edwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4351-0DOI Listing
September 2017

Closing the gap: astrocytes and brain metastasis.

Cell Res 2016 09 12;26(9):973-4. Epub 2016 Aug 12.

Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034114PMC
http://dx.doi.org/10.1038/cr.2016.96DOI Listing
September 2016

Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment.

J Natl Cancer Inst 2016 Feb 7;108(2). Epub 2015 Nov 7.

: Edwin L. Steele Laboratories, Department of Radiation Oncology (VA, GBF, DPK, MB, RCS, GS, JK, TV, JDM, KN, DB, XQ, DGD, PH, DF, RKJ), Department of Pathology (MKS, EB), and Department of Medicine, Cancer Center (JAE), Massachusetts General Hospital and Harvard Medical School, Boston MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862418PMC
February 2016

Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.

J Natl Cancer Inst 2015 Apr 20;107(4). Epub 2015 Feb 20.

Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston MA (EIA, SVK, NDK, GS, DPK, VA, YH, SG, MS, YB, DF, RKJ); Department of Surgery (Austin Health), University of Melbourne, Studley Road Heidelberg, VIC, Australia (EIA); Novogen, Hornsby, NSW, Australia (EIA); Novartis Institutes for BioMedical Research, Cambridge, MA (NDK); Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney, Camperdown, NSW, Australia (SG); Department of Biostatistics, Massachusetts General Hospital Biostatistics Center, Boston, Massachusetts (AM, DMF); Department of Pathology, NYU Langone Medical Center and Medical School, New York, NY (MS); Dyax Corp., Burlington, MA (DTD, LD); Departments of Medical Oncology and Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (SG); Tokai Pharmaceuticals, Inc., Cambridge, MA (DTD); Merck Serono S. A., Geneva, Switzerland (LD).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402365PMC
April 2015

Emerging strategies for treating brain metastases from breast cancer.

Cancer Cell 2015 Feb;27(2):163-75

Edwin L. Steele Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108150001
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325273PMC
February 2015

mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1.

Cancer Discov 2014 Jan 25;4(1):42-52. Epub 2013 Oct 25.

1Massachusetts General Hospital Cancer Center; 2Department of Medicine, Harvard Medical School; 3Division of Gastroenterology, Department of Medicine, Tufts Medical Center; 4Department of Pathology, Massachusetts General Hospital, Boston; and 5Radiation Oncology, Steele Lab for Tumor Biology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973435PMC
January 2014

The biology of brain metastases-translation to new therapies.

Nat Rev Clin Oncol 2011 Jun 12;8(6):344-56. Epub 2011 Apr 12.

Stephen E. and Catherine Pappas Center for Neuro-oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2011.58DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259742PMC
June 2011

Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques.

Stem Cells 2007 Nov 9;25(11):2936-44. Epub 2007 Aug 9.

Burnett College of Biomedical Sciences, University of Central Florida, 4000 Central Florida Boulevard, Orlando, Florida 32816, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1634/stemcells.2007-0216
Publisher Site
http://dx.doi.org/10.1634/stemcells.2007-0216DOI Listing
November 2007